{"id":"W4306843199","doi":"10.1182/bloodadvances.2022008747","title":"An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS","year":2022,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; National Institutes of Health; Astellas Pharma; Incyte; Astex Pharmaceuticals; Gilead Sciences; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Acceleron; Celgene; Bristol-Myers Squibb; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Cardinal Health; Amgen; National Heart, Lung, and Blood Institute; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Myelodysplastic syndromes; MEDLINE; Medicine; Computer science; Political science; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001468869,0.0001905394,0.0003288181,0.0004769517,0.0003092095,0.00007223542,0.001102028,0.0000617614,0.001473641],"category_scores_gemma":[0.001421122,0.0001577369,0.00005174975,0.001893537,0.0001740745,0.0003515666,0.0007138732,0.001485799,0.00006638023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008149455,"about_ca_system_score_gemma":0.0004140052,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009020711,"about_ca_topic_score_gemma":0.00463925,"domain_scores_codex":[0.9964941,0.0003534805,0.0004114554,0.0007204118,0.001352934,0.0006676058],"domain_scores_gemma":[0.9971792,0.001735047,0.00005997419,0.0007003777,0.0001470847,0.0001783675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006061161,0.004139998,0.860904,0.0002295169,0.000230639,0.007294236,0.01306108,0.01014531,0.004842444,0.0008043861,0.01198118,0.08030599],"study_design_scores_gemma":[0.005818732,0.001182657,0.2310852,0.0005404733,0.00002923939,0.0001684517,0.01277532,0.002274414,0.0005849439,0.0009223267,0.744192,0.0004262386],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787601,0.002740595,0.00005847596,0.01499598,0.0003604273,0.0009792891,0.0001219582,0.00004961844,0.001933508],"genre_scores_gemma":[0.9942143,0.0003773958,0.001723625,0.0008243024,0.0003601978,0.000610852,0.00009720932,0.00003689742,0.00175521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7322108,"threshold_uncertainty_score":0.9994391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04899527071681768,"score_gpt":0.3902732719126943,"score_spread":0.3412780011958766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}